ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

O’Connor Is New NS President, Curtiss Is Next

May 24, 1991

TGen’s Trent To Lead Van Andel Institute

February 13, 2009

Michigan Scientist David Beer Sought Retraction Of Potti’s NEJM Paper Over Misuse Of His Data

July 30, 2010

In Brief: Jay Moskowitz Reassigned; Healy To Run For Ohio Republican Nomination To Senate

September 17, 1993

AIDS Vaccine Intervention Progress Reported

July 5, 1985

New Mexico CBCCP Charges Contracts Terminated for “Mundane Political, Economic” Factors

April 25, 1980